Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Hossann

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Current Opinion in Drug Discovery & Development|January 5, 2010
Factors affecting drug release from liposomesLars H Lindner, Martin Hossann
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 30, 2008
Quantification of erufosine, the first intravenously applicable alkylphosphocholine, in human plasma by isotope dilution liquid chromatography-tandem mass spectrometry using a deuterated internal standardLars H Lindner, Hansjoerg Eibl, Martin Hossann, et al.
Biochemical and Biophysical Research Communications|June 22, 2005
On the contentious sequence and glycosylation motif of the ribosome inactivating plant protein geloninThorsten Daubenfeld, Martin Hossann, Wolfgang E Trommer, et al.
International Journal of Nanomedicine|September 27, 2014
Thermosensitive liposomal drug delivery systems: state of the art reviewBarbara Kneidl, Michael Peller, Gerhard Winter, et al.
International Journal of Pharmaceutics|June 17, 2025
Local drug delivery of irinotecan with phosphatidyldiglycerol-based thermosensitive liposomes reduces systemic exposure and increases therapeutic efficacy compared to systemic drug and Onivyde®Barbara Wedmann, Simone Kort, Lisa Pointner, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 2, 2016
Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumorsMichael Peller, Linus Willerding, Simone Limmer, et al.
Biochimica Et Biophysica Acta|July 10, 2007
In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomesMartin Hossann, Michael Wiggenhorn, Alenka Schwerdt, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 5, 2012
Proteins and cholesterol lipid vesicles are mediators of drug release from thermosensitive liposomesMartin Hossann, Zulfiya Syunyaeva, Rebecca Schmidt, et al.
International Journal of Nanomedicine|June 24, 2021
Effects of Surface Charge, PEGylation and Functionalization with Dipalmitoylphosphatidyldiglycerol on Liposome-Cell Interactions and Local Drug Delivery to Solid Tumors via Thermosensitive LiposomesMatteo Petrini, Wouter J M Lokerse, Agnieszka Mach, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 21, 2007
Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: active ingredient and mediator of drug releaseLars H Lindner, Martin Hossann, Michael Vogeser, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Current Opinion in Drug Discovery & Development|January 5, 2010
Factors affecting drug release from liposomesLars H Lindner, Martin Hossann
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 30, 2008
Quantification of erufosine, the first intravenously applicable alkylphosphocholine, in human plasma by isotope dilution liquid chromatography-tandem mass spectrometry using a deuterated internal standardLars H Lindner, Hansjoerg Eibl, Martin Hossann, et al.
Biochemical and Biophysical Research Communications|June 22, 2005
On the contentious sequence and glycosylation motif of the ribosome inactivating plant protein geloninThorsten Daubenfeld, Martin Hossann, Wolfgang E Trommer, et al.
International Journal of Nanomedicine|September 27, 2014
Thermosensitive liposomal drug delivery systems: state of the art reviewBarbara Kneidl, Michael Peller, Gerhard Winter, et al.
International Journal of Pharmaceutics|June 17, 2025
Local drug delivery of irinotecan with phosphatidyldiglycerol-based thermosensitive liposomes reduces systemic exposure and increases therapeutic efficacy compared to systemic drug and Onivyde®Barbara Wedmann, Simone Kort, Lisa Pointner, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 2, 2016
Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumorsMichael Peller, Linus Willerding, Simone Limmer, et al.
Biochimica Et Biophysica Acta|July 10, 2007
In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomesMartin Hossann, Michael Wiggenhorn, Alenka Schwerdt, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 5, 2012
Proteins and cholesterol lipid vesicles are mediators of drug release from thermosensitive liposomesMartin Hossann, Zulfiya Syunyaeva, Rebecca Schmidt, et al.
International Journal of Nanomedicine|June 24, 2021
Effects of Surface Charge, PEGylation and Functionalization with Dipalmitoylphosphatidyldiglycerol on Liposome-Cell Interactions and Local Drug Delivery to Solid Tumors via Thermosensitive LiposomesMatteo Petrini, Wouter J M Lokerse, Agnieszka Mach, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 21, 2007
Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: active ingredient and mediator of drug releaseLars H Lindner, Martin Hossann, Michael Vogeser, et al.
Pageof 3